4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-000276
President & CEO sold 19,582 shares at $45.57 ($892,352)
From the SEC's structured data for this filing
Trades in this filing
KAKKIS EMIL D · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-30 | Sale : show line 1 in the form | −19,582 | $45.57 | $892,352 | 541,108 | D |
| Open-market sales · 19,582 sh · avg $45.57 · $892,352 | ||||||
Loading xslF345X03/doc4.xml…